Unique Biotechnology: At present, the production and operation activities are normal and there are no significant issues that should be disclosed but have not been disclosed.

WeTV announced on September 24 that the company's stock has had a deviation in closing price exceeding 30% for three consecutive trading days, which falls under the category of abnormal stock price fluctuation according to the relevant regulations of the Shenzhen Stock Exchange. Upon verification, the company's recent production and operation are normal, and there have been no significant changes in the internal and external operating environment, nor are there any anticipated major changes. The company, as well as its controlling shareholder and actual controller, have not withheld any major disclosure obligations or are in the process of planning any major matters. The company has not found any recent public media reports that may have a significant impact on the trading price of its stock. The controlling shareholder and actual controller of the company have not engaged in buying or selling the company's stock during the period of abnormal stock fluctuations.